Imbruvica plus venetoclax significantly extends PFS in untreated CLL patients compared to chlorambucil plus Gazyva, with 52 months versus 31 months. The combination therapy shows durable efficacy and ...

Imbruvica is a first-in-class, once-daily, oral Bruton's tyrosine kinase (BTK) inhibitor that promises blockbuster status. Peak sales of between $4-6.5 billion are predicted, if it can add further ...

Starting Jan. 1, older adults on Medicare will spend no more than $2,000 a year on prescription drugs when a new price cap on ...

A head-to-head trial of Brukinsa versus Imbruvica in WM failed to show a significant improvement over AbbVie and J&J's drug, although there was a trend towards superiority in the numbers.

Do not freeze. Dispense in the original sealed container. Discard any unused Imbruvica oral suspension remaining 60 days after first opening the bottle. ≥12 years old with total bilirubin level ...

Sales of Humira and Imbruvica declined in the quarter. All growth rates mentioned below are on a year-on-year basis and at ...